Navigation Links
Cancer Survivors Call in Sick to Work More Often, Study Finds
Date:6/21/2012

THURSDAY, June 21 (HealthDay News) -- While many long-term cancer survivors return to work, they take more sick leave than their cancer-free colleagues, a new study finds.

Researchers analyzed data from more than 2,000 employed cancer survivors in Norway and more than 3,200 healthy people, and found that 75 percent of cancer survivors took sick leave during the first year after their diagnosis.

During the next four years, 23 percent of men and 31 percent of women recovering from cancer took sick leave, compared with 18 percent of healthy men and 27 percent of healthy women.

The investigators found that socio-demographic factors were more important predictors of sick leave during the five years of follow-up than the type or severity of cancer. These factors included being single with children, having a low level of education, working in the health and social care sector, and having taken sick leave before cancer diagnosis.

The study was released online June 16 in advance of publication in an upcoming print issue of the Journal of Cancer Survivorship.

"Employed long-term cancer survivors may struggle with health impairments or reduced work ability five years after diagnosis. A socioeconomic and work environmental perspective seems necessary for occupational rehabilitation and the health and safety of cancer survivors, in order to reduce the rate of sick leave in this group," Steffen Torp, of Vestfold University College in Norway, and colleagues concluded in a journal news release.

The ability to work is important to help cancer survivors maintain self-respect, identity and their living standard. Previous research has shown that most cancer survivors return to work, but many report a reduced ability to work.

More information

The U.S. National Cancer Institute offers an overview of life after cancer treatment.

-- Robert Preidt

SOURCE: Journal of Cancer Survivorship, news release, June 19, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Multiple sclerosis patients have lower risk of cancer: UBC-VCH research
2. Moffitt researchers: Darwins principles say cancer will always evolve to resist treatment
3. Misidentified and contaminated cell lines lead to faulty cancer science
4. Study links carcinogens to cancer stem cells -- but spinach can help
5. Breast cancers many drivers
6. UW research shows new prognosis tool for deadly brain cancer
7. New drugs, new ways to target androgens in prostate cancer therapy
8. Mayo Clinic: Molecule thought cancer foe actually helps thyroid tumors grow
9. Could Sunlight Lower Your Odds for Pancreatic Cancer?
10. New Therapies Show Some Promise Against Pancreatic Cancer
11. Leukemia inhibitory factor may be a promising target against pancreatic cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Datos Health , developer of a pioneering ... , the largest Electronic Medical Records (EMR) provider in South Africa. By using ... a patient’s remote health progress, empowering the patient to take direct responsibility for their ...
(Date:4/26/2017)... Jersey City, NJ (PRWEB) , ... April 26, 2017 , ... ... that offers an easy way to get nutrients from SUPERFOODS! , RawTrition ... the body at the cellular level because the body recognizes its raw form (unlike ...
(Date:4/25/2017)... ... ... Bellus Medical, a leader in medical aesthetics, recently acquired ... photodynamic cosmetics (PDC). , Allumera® is the first PDC cream specifically formulated to ... minimize the appearance of pores – all with minimal downtime and results that ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... CEOs, CFOs and HR decision-makers are preparing for how his administration could impact ... will provide insight into what changes are most likely to make it through ...
(Date:4/25/2017)... ... 25, 2017 , ... As pharmaceutical companies are held to ... process innovation in drug formulation and manufacturing. CoreRx offers its clients more ... in support of their development and manufacturing goals. , The company was ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 Global Surgical ... devices are tubes used to remove excess liquid and ... serum, pus, urine, bile or lymph. Surgical drains are ... surgery such as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic ... prophylactic post-surgery to prevent accumulation of fluid e.g. blood ...
(Date:4/19/2017)... SAN DIEGO , April 19, 2017 /PRNewswire/ ... ("Sorrento"), an antibody-centric, clinical-stage biopharmaceutical company developing new ... today announced the closing of its previously announced ... common stock at a public offering price of ... commissions and estimated offering expenses payable by Sorrento.  ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology: